Status: Recruiting
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
Participants needed: 80
Trial details
Age: 40-75Biological sex: AllType: InterventionalSponsor: Synbiotic HealthUpdated: Apr 22, 2026Locations: 1
Eligibility criteria
Aged 40-75 years. [+2]
Chronic disease history (liver, kidney, heart). [+14]